During embryonic development, programmed cell death (PCD) shapes the embryo, enabling proper development of tissues and organs (Domingos and Steller, 2007; Henson and Hume, 2006; Hipfner and Cohen, 2004; Learte et al., 2008) . Specifically, PCD in the developing nervous system has been demonstrated in Drosophila as well as in higher organisms (Brachmann and Cagan, 2003; Buss et al., 2006; Rogulja-Ortmann et al., 2007) . PCD of the midline glial (MG) cells of the Drosophila embryonic central nervous system (CNS) has served as a model system in which to study regulatory mechanisms associated with stage-and cell-specific induction of PCD Giesen et al., 2003) .
Introduction
During embryonic development, programmed cell death (PCD) shapes the embryo, enabling proper development of tissues and organs (Domingos and Steller, 2007; Henson and Hume, 2006; Hipfner and Cohen, 2004; Learte et al., 2008) . Specifically, PCD in the developing nervous system has been demonstrated in Drosophila as well as in higher organisms (Brachmann and Cagan, 2003; Buss et al., 2006; Rogulja-Ortmann et al., 2007) . PCD of the midline glial (MG) cells of the Drosophila embryonic central nervous system (CNS) has served as a model system in which to study regulatory mechanisms associated with stage-and cell-specific induction of PCD Giesen et al., 2003) .
MG cells are required for various processes in the developing CNS, including the guidance of the commissural growth cones across the midline, the separation of the anterior and posterior commissurs, as well as their ensheathment (Auld, 2001; Granderath and Klambt, 1999; Klambt and Goodman, 1991) . The MG cells arise from the anterior mesectodermal (MEC) precursors defined by the transcription factor, Singleminded (Sim), which then divide to generate six MG cells (at stage-9) at the anterior portion of each segment (Bossing and Technau, 1994; Klambt and Goodman, 1991) . At this time, the expression of sim along the midline is restricted to the three pairs of MG cells (Nambu et al., 1990; Rothberg et al., 1990) . The subsequent differentiation and survival of MG cells is controlled by Drosophila EGF-receptor (DER) signaling (Chen and Rebay, 2000; Scholz et al., 1997; Stemerdink and Jacobs, 1997) .
As part of their inherent differentiation program, a pair of MG cells migrate towards the posterior commissure of the 0925-4773/$ -see front matter Ó 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2008.10.004 more anterior segment, at which time they undergo apoptosis (Klambt and Goodman, 1991) . Often, apoptosis is also observed among the more anterior MG cells, so that by stage 16 of embryonic development, only 3-4 MG cells survive in each segment. Apoptosis of the MG cells depends on the activity of the pro-apoptotic genes Hid and Reaper, which are both expressed in the MG cells (Dong and Jacobs, 1997; Jacobs, 2000; Zhou et al., 1997) . Significantly, in embryos homozygous for a deficiency that deletes the three pro apoptotic genes hid, reaper and grim, the number of MG cells is increased. In addition, activation of the Egfr pathway in MG cells by the Spitz ligand produced by the axons attenuates the Hid-induced apoptotic signal due to the phosphorylation of Hid by MAPK, which arrests Hid activity . Thus, the determination of MG cell number during CNS development represents an interesting system in which a delicate balance between death and survival signals within these cells determines their fate.
A candidate signal that might positively regulate pro apoptotic gene expression in MG cells during embryonic development is the steroid hormone, Ecdyson (Ecd). During the period of fly metamorphosis, the Ecdyson pathway directs the massive and rapid destruction of larval tissues via PCD by inducing elevation of the pro apoptotic genes hid and reaper as well as repression of the levels of diap1 (Yin and Thummel, 2005) . Importantly, a group of genes called ''Halloween genes'' that mediate Ecd synthesis were identified in a genetic screen as genes required for embryonic CNS development, and were shown to contribute to specifying the correct number of MG cells (Giesen et al., 2003) . Thus the Ecd pathway might be active during embryogenesis upstream of the pro apoptotic genes hid and reaper to induce MG cell apoptosis.
The death of a subset of the MG cells might be explained by differential levels of Hid and Reaper, or by the duration of their exposure to the apoptotic signal. It is conceivable that the MG cells that migrate for longer distances are exposed to the apoptotic signal for a longer duration, resulting in their probable death prior to receiving the survival signal produced by the axons. Thus, in this system, a delicate balance between pro-and anti-apoptotic signals operates to control a partial loss of MG cells so only the correct numbers of MG cells survive to the end of embryogenesis.
Here, we demonstrate that the activity of the product of the gene held out wing (HOW), is required to enhance MG sensitivity to apoptotic signals. HOW is an RNA-binding protein, which is a member of the STAR family (Signal Transduction and Activation of RNA) of RNA-binding proteins that share several structural similarities, including a single maxi KH-domain flanked by two additional QUA1 and QUA2 domains (reviewed in (Volk et al., 2008) . HOW binding to a conserved RNA sequence motif within the 3 0 UTR of a given mRNA species alters the target mRNA levels (Israeli et al., 2007; Toledano-Katchalski et al., 2007) . The how gene is spliced into short (how(S)) and long (how(L)) splice variants (Nabel-Rosen et al., 2002) . HOW(L) is detected at early stages of embryonic development in various tissues, including the mesoderm and its muscle derivatives, as well as in tendons and peripheral glia. Previous experiments suggested that HOW(L) acts as a repressor of mRNA levels. In this study, we show that HOW is highly expressed in MG cells, and that in how mutant embryos, the number of MG cells is elevated due to reduced apoptosis; this phenotype can be rescued by the expression of the repressor isoform, HOW(L). Finally, we demonstrate that HOW(L) reduces the levels of the anti-apoptotic protein Diap1 in MG cells, both at the protein and mRNA levels. We suggest that this reduction leads to a higher sensitivity of MG cells to pro-apoptotic signals.
Results

HOW is expressed in MG cells
The vertebrate homologue of HOW, Quaking is highly expressed in oligodendrocytes and in Schwann cells (Chen et al., 2007; Hardy et al., 1996) . This led us to characterize the expression pattern of HOW in the Drosophila CNS. We first examined the CNS of wild type embryos at stage 16 stained for the pan-glial cell marker, Repo, and for HOW. We show that HOW partially overlaps the Repo pattern in peripheral glia (Edenfeld et al., 2006) , as well as glia located at the edges of the CNS, presumably representing subperineurial and/or perineurial glia. Longitudinal and cortex glia did not express HOW, while in the midline, we detected HOW positive and Repo-negative cells (Fig. 1A-D, arrows) . To further establish the identity of these cells, we labeled a midline glial-specific enhancer trap line (AA142) with anti-b-gal and with anti-HOW. We show that HOW staining overlapped the b-gal staining ( Fig. 1E-H, arrows) . In addition to MG cells HOW staining was evident in midline cells which were also repo positive (Fig. 1A-D, arrowheads) . These cells might represent channel glia. Thus HOW is expressed in sub-populations of glial cells, and is prominent in the midline glial cells.
HOW is essential for apoptosis of MG cells
To evaluate the function of HOW in midline glial cells, we examined the number and location of these cells in how mutant embryos. The mutant allele, how stru , was recombined with the enhancer trap AA142 to enable detection of the midline glial cells in how homozygous mutant embryos. Throughout this analysis, we use the how stru allele found to represent a null allele (see Section 4). The number of the AA142-positive MG cells was significantly elevated in stage 15 how mutant embryos (Fig. 2) . how mutant embryos at later stages (e.g. stage 16, Fig. 2C and D) also showed the same phenotype, suggesting that this phenotype did not result simply from delayed embryonic development that occurs in how mutants. While wild type embryos exhibited 3-4 MG cells, which were all in contact with the commissures, how stru mutant embryos exhibited between 4-6 MG cells (Fig. 2) . The average of segmental MG cells in wild type (WT) and how stru mutant embryos were 3.2 ± 0.1 (n = 58 segments) versus 4.3 ± 0.1 (n = 71 segments) cells/segment, respectively. In how stru mutant embryos 28/71 counted segments showed more than five MG cells/segment (40% penetrance, P < 0.01) whereas in wild type embryos, we observed five MG cells in only 1% of the segments. We noticed that the length of the ventral cord is slightly larger in these embryos. This phenotype is possibly due to additional requirements for HOW in other glial cells.
The excess in the number of MG cells may result from elevated cell divisions, or alternatively from inhibition of cell death. The levels of activated effector caspase (using antiactivated Caspase3 antibody) in the how mutant embryos were examined to evaluate whether apoptosis occurs at similar extent in the mutant as in wild type embryos. This analysis showed that the number of cells expressing activated effector caspase is significantly reduced in the how mutant embryos (Fig. 3, arrows) which is consistent with the idea that apoptosis of MG cells is reduced in the how mutant embryos.
2.3.
The repressor HOW(L) is sufficient to rescue the number of midline glial cells
The single how gene produces two protein isoforms by alternative splicing, HOW(L) which has been shown to repress mRNA levels, and HOW(S) which is involved in mRNA stability and pre mRNA splicing. To gain insight as to which isoform mediates the function of HOW in midline glial PCD, we performed rescue experiments with each of the HOW isoforms. The sim-gal4 driver was used to drive the expression of each HOW isoform in the midline glia cells in the homozygous how mutant embryos, carrying the AA142 marker for midline glia cell identification. The number of midline glia was counted in each segment of the various genotypes. The HOW(L) isoform rescued the number of midline glial cells to 3 ± 0.1 cells per segment (n = 42 segments) (Fig. 4D ). Over expression of HOW(S) in how stru mutants resulted in an average of 4.1 ± 0.1 MG cells per segment (n = 50) (Fig. 4 , bar graph), similar to that seen in the unrescued how stru mutant. Interestingly, over expression of HOW(L) in wild type embryos induced a reduction of the average number of midline glia cells to 2.4 ± 0.1 (n = 39 segments) ( Fig. 4B ) while over expression of HOW(S) in wild type embryos led to 2.8 ± 0.2 MG cells/ segment (n = 12) which is not significantly different from the wild type number (Fig. 4 , bar graph). The differences between the groups were proven to be statistically significant by ANO-VA test followed by Dunn's test. Thus, HOW(L) represents the major HOW isoform capable of rescuing the excess of MG cells in how mutant embryos. HOW(S) does not appear to contribute significantly to the process responsible for the reduction of MG cell number. 
diap1 levels are elevated in the MG cells of how mutant embryos
Previous studies showed that the midline glia cells are unique in that they normally express high levels of the pro-apoptotic gene product, Hid and Reaper, explaining their sensitivity to apoptosis (Zhou et al., 1997) . We examined the levels of the pro-apoptotic protein Hid and the anti apoptotic protein Diap1 in the MG cells of how mutant embryos. Whereas the levels of Hid appeared to be similar in MG cells of wild type and how mutant embryos (not shown), the levels of Diap1 were significantly elevated in the MG cells in how mutant embryos ( Fig. 5A-D) . Since the rescue experiments showed that HOW(L) is the isoform that provides rescue of MG cell number, and given that HOW(L) represses mRNA levels in other experimental settings, a possible direct effect of HOW(L) on Diap1 (either at the mRNA or protein levels) was further examined.
To determine whether HOW(L) affects Diap1 levels, we first tested the levels of Diap1 in S2 cells following reduction of HOW levels by dsRNA. Diap1 and HOW(L) are both endogenously expressed in S2 cells. Three independent experiments in which the endogenous levels of HOW were significantly reduced by the addition of HOW-specific dsRNA showed a consistent increase of Diap1 protein levels by 1.6-fold (Fig. 5E) . Note that Western analysis with affinity purified anti Diap1 antibodies shows two bands representing the intact unprocessed Diap1 (upper band) and the processed cleaved band (lower band) which lack the first 20 amino acids as described (Ditzel et al., 2003) . To further study the potential 2), using the sim-gal4 driver. The difference between the groups was found to be statistical significance by the ANOVA test followed by Dunn's method.
direct link between HOW(L) and Diap1 levels, the S2 cells were transfected with UAS-how(L) and UAS-gfp together with actingal4 and the effect of endogenous Diap1 levels was analyzed. Transfected cells were selected by FACS according to their GFP expression, collected and tested for Diap1 levels by Western analysis. A significant reduction in the levels of endogenous Diap1 protein was detected in the HOW(L) over expressing cells (Fig. 5F ). In addition, over expression of HOW(L) in embryos using the heat-shock-gal4 driver was performed to drive expression of HOW(L) in embryos at stages 12-14. Following a 1 h heat shock pulse (at 37°C), and additional 2 h of incubation (at 25°C), the proteins were extracted from the embryos and the levels of Diap1 were analyzed by Western analysis. Consistent with the experiments in S2 cells, a significant reduction in endogenous Diap1 levels was observed (Fig. 5G) . Since HOW is an RNA-binding protein it could affect directly the mRNA levels of diap1. To address this we examined the mRNA levels of diap1 in S2 cells over expressing HOW(L). Semi-quantitative RT-PCR shows that indeed diap1 RNA levels were reduced (Fig. 5H represents three independent repetitions of this experiment).
The 3 0 UTR of diap1 contains two binding sites for HOW.
HOW-binding experiment between in vitro translated HOW(L) and diap1 mRNA shows a specific binding of HOW to diap1 mRNA (Fig. 5I) . Moreover, deletion of the two HOW-binding sites from diap1 3 0 UTR, abrogated the ability of HOW(L) to repress Diap1 levels in S2 cells (Fig. 5J) . Taken together, the loss of function and gain of function experiments with HOW(L) indicate that Diap1 is negatively regulated by HOW(L), by interacting with its 3 0 UTR.
HOW expression in glial cells depends on the Ecdyson pathway
Previous studies demonstrated that the Ecdyson (Ecd) signaling pathway is essential for the induction of the correct number of MG cells, as mutants in genes encoding for various components in the Ecd biosynthetic pathway exhibit an increased number of MG cells (Giesen et al., 2003) . Importantly, how was identified as a down stream target gene in the Ecd signaling pathway during fly metamorphosis (Baehrecke, 1997) . We found that HOW levels are reduced in disemboided (dib) embryos mutant in the biosynthetic pathway of Ecdysone, and that this reduction is detected especially in the CNS (Fig. 6 ). This suggests that HOW(L) is positively regulated by the Ecd pathway in MG cells, and may mediate the effect of Ecd on MG cell number. Because our experiments suggest that HOW(L) represses Diap1 levels in the MG cells, we analyzed the levels of Diap1 protein in these cells in dib mutant embryos, and in dib mutants over expressing HOW(L) driven by the midline specific driver sim-gal4. Significantly, Diap1 levels were reduced in dib mutant embryos ectopically expressing HOW(L) in the MG cells (driven by sim-gal4) (Fig. 7) . However, the reduction in Diap1 levels was not sufficient to induce apoptosis of the MG cells, presumably due to the lack of pro-apoptotic signals in the mutant embryos. It was noted that although the sim-gal4 driver drives expression in all midline glia cells, the ectopic expression of HOW in the MG cells was variable. This could be due to differential degradation of HOW in these cells. We assume that during earlier developmental stages all midline glia cells expressed HOW, and therefore Diap1 levels were reduced in all MG cells.
Discussion
The sensitivity of cells to apoptotic signals depends on the balance between the pro-apoptic and anti-apoptotic signals expressed within a cell in a given developmental context. MG cells represent a unique system in which to study apoptosis because only a small subset of the cells (2-3 out of 6) are doomed to die, and the death must be executed in a relative short period of time (around 3 h), during the migration of the AMG pair towards the next segment. We show here that HOW functions to enhance the sensitivity of these cells to the pro apoptotic signals by reducing the levels of the antiapoptotic protein, Diap1.
Regulation through pro apoptotic signals, e.g. the activities of Reaper, Grim and Hid (RGH) proteins, or the anti-apoptotic signal, by influencing the activity of Diap1, enables cells to respond to a wide array of signaling pathways (Domingos and Steller, 2007; Hay et al., 2004) . The convergence of these signals in a single cell determines not only whether the cell will undergo PCD, but also the timing during development at which this process will occur. In case of MG cells, the timing is critical, as the cells die prior to their arrival to the commissure, and thus do not receive the survival signal through MAPK activation .
RGH proteins were shown to affect the levels of Diap1 at several regulatory stages. Reaper and Hid affect Diap1 levels via ubiquitination and proteosomal degradation (Ryoo et al., 2002; Yoo et al., 2002) . In addition, Morgue has been shown to promote Diap1 degradation (Hays et al., 2002) whereas Reaper was shown to also inhibit translation of diap1 (Yoo et al., 2002) . Despite the expression of Hid and Reaper in MG cells, only partial PCD is induced in these cells, possibly due to high levels of Diap1 (Zhou et al., 1997) .
The effect of HOW on MG cell death
Our previous data suggest that HOW(L) mediates developmental processes in other tissues (e.g. mesoderm, tendon cells), by a temporal reduction of the levels of key regulatory proteins. For example, in gastrulating embryos, HOW(L) reduces the mRNA levels of string/cdc25 to arrest cell division during mesoderm invagination (Nabel-Rosen et al., 2005) , and at a later stage, HOW(L) reduces the levels of miple1 to allow mesoderm spreading (Toledano-Katchalski et al., 2007) . Similarly, we show here that HOW contributes to the timing of MG cell apoptosis by reducing the levels of Diap1, thereby sensitizing these cells to pro-apoptotic signals. We do not favor an effect of HOW on cell division through regulation of String since HOW is detected in the midline cells only at stage 12-13 at which the MG cells do not divide anymore.
Several lines of evidence support the idea that HOW(L) might affect MG cell apoptosis through its repression of Diap1 levels. First, we show by antibody staining that Diap1 levels are elevated in how mutants. Second, reducing HOW levels by introducing HOW-specific dsRNA or elevating HOW(L) levels in S2 cells leads to corresponding opposing effects on Diap1 protein expression, elevation of Diap1 when HOW is reduced and reduction of Diap1 when HOW(L) is elevated. The diap1 3 0 UTR contains two binding sites for HOW, and is capable of binding to HOW(L) in vitro. Nevertheless, we could not detect a corresponding elevation of diap1 mRNA in the S2 cells in which HOW was knocked down by dsRNA, possibly due to a continuous positive transcriptional input of diap1 in these cells. However, a reduction of diap1 mRNA and protein levels was induced, following over expression of HOW(L) in S2 cells and in embryos. We also examined whether the splicing pattern of diap1 was altered in S2 cells depleted of HOW, as HOW was demonstrated to mediate alternative splicing in other tissues. To this end, we performed an RT-PCR with primers specific for each of the three diap1 splice variants; however, no change in the pattern of diap1 splicing was observed (not shown). Thus, HOW(L) might affect Diap1 protein levels by repressing both its mRNA levels as well as its translation. Alternatively it could affect Diap1 indirectly by influencing the levels of an upstream regulator of Diap1. Our results support a direct effect of HOW through its association with the HOWbinding sites in diap1 3 0 UTR, as deletion of these sites abrogated the reduction of Diap1 detected in the presence of HOW(L).
Gld-1 the C. elegans orthologue of HOW affects both translation and stability of its target mRNAs, apparently by affecting the length of the polyA tail of the target mRNA (Ciosk et al., 2004; Jan et al., 1999; Lee and Schedl, 2004) . HOW(L) might act in a similar fashion on diap1 mRNA.
Whereas HOW(L) does not induce apoptosis in other tissues, where it is highly expressed (e.g. mesoderm, tendon cells etc.), it was shown to have pro apoptotic effects in MG cells and in the adult fly eye (Reuveny et al., unpublished data). We suspect that in these tissues, a delicate balance between the levels of the pro apoptotic and anti apoptotic proteins is maintained, so that the cells become highly sensitive to Diap1 levels, and thus are responsive to reduced or elevated levels of HOW(L).
Interestingly, one isoform of the mammalian orthologue of HOW, Quaking7 (QKI-7), has been shown to induce apoptosis b of fibroblasts and primary rat oligodendrocytes (Pilotte et al., 2001) . The molecular mechanism of QKI-7-induced apoptotic activity has yet to be elucidated, but the unique C 0 terminal tail of QKI-7 appears to be necessary for this apoptotic activity. In contrast, C. elegans GLD-1 was shown to repress the levels of cep1 an orthologue of mammalian P53 (Schumacher et al., 2005) . In that system, GLD-1 exhibits an anti apoptotic effect. It appears therefore, that STAR proteins are not dedicated to a defined direction of apoptotic regulation. Rather, their basic activity is to elevate or reduce the levels of critical components in the process to enable the execution of PCD or to allow other developmental process to occur.
A link between the steroid hormone Ecdyson pathway and HOW
Previous studies demonstrated that how transcription is induced in response to the activation of the Ecdyson (Ecd) pathway (Baehrecke, 1997) however, the biological significance of this induction was not clear. During larval stages, a high titer of Ecd acts through the ecdyson receptor EcR/Ultraspiracle nuclear receptor heterodimer to signal puparium formation and destruction of several larval tissues including the midgut and salivary glands (Baehrecke, 2003; Yin and Thummel, 2005) . The Ecd pathway triggers a transcriptional cascade that culminates in rpr and hid induction to initiate tissue destruction. Interestingly, the Ecd pathway induces parallel repression of diap1 via the activity of the CREB binding protein, CBP (Yin et al., 2007) . CBP is both necessary and sufficient to down-regulate Diap1, providing the cells with the competence to die. Whereas the contribution of CBP to MG cell apoptosis has yet to be elucidated, it is possible that in this system, in parallel to the induction of CBP transcription, the Ecd pathway triggers HOW(L) transcription to enhance Diap1 destruction, possibly due to a need to induce rapid death of the MG cells.
To address whether HOW(L) is sufficient to rescue the excess in MG cells in dib mutant embryos, we over expressed HOW(L) in dib mutant embryos that carried the MG-specific enhancer trap, AA142, using the sim-gal driver. Embryos over expressing HOW(L) in dib mutant embryos still maintained a high number of MG cells, suggesting that HOW(L) is not sufficient to rescue the dib mutant phenotype. Importantly, the levels of Diap1 in MG cells in these embryos were significantly reduced.
The inability of HOW(L) to reduce the number of MG cells following its over expression in the dib mutant embryos might be explained by the involvement of the Ecd pathway not only in PCD but also in repression of MG cell division in an earlier developmental stage as suggested by Giesen et al. (Giesen et al., 2003) . Also, since the Ecdysone pathway positively regulates Hid, it is possible that the MG cells did not contain enough pro-apoptotic signals to induce PCD, and therefore it is not surprising that HOW(L) did not provide rescue of the MG cell number.
In summary, we have identified the KH-domain RNA-binding protein, HOW, as a novel regulator of PCD in MG cells, likely acting as a regulator of Diap1 translation and/or stability. We propose that HOW provides the MG cells with enhanced sensitivity to the pro apoptotic effects of Hid and Reaper, triggering the rapid apoptosis of MG cells during their migration.
4.
Experimental procedures
Fly stocks
The following strains were used: yw (wild type strain), Dr/ TM3 Sb GFP, how stru3R-3 /TM3 Sb GFP. We analyzed this allele molecularly and found that it deletes 18 nucleotides that partially overlap the intron-exon junction of the 3rd exon of how. This leads to change in the ORF and premature termination, consistent with the lack of antibody staining of these mutant embryos. Additional strains used: UAS-how(L) and UAS-how(S) (Nabel-Rosen et al., 1999); P-lacZ enhancer--trap strains AA142, sim::gal4 and dib;AA142/TM6 were provided by Prof. Christian Klä mbt (Mü nster, Germany).
The following recombinant lines were created by standard crosses: UAS-how(L)/cyo; how stru , AA142/TM6,BB or UAS-how (S)/cyo; how stru , AA142/TM6BB or sim-gal4/cyo; how stru , AA142/TM6BB. In addition, UAS-how(L)/cyo; dib, AA142/ TM6,BB or UAS-how (S)/cyo; dib, AA142/TM6BB or sim-gal4/ cyo; dib, AA142/TM6BB, and were obtained. Secondary antibodies: Cy3, Cy5, Flurecine (FITC), or HRP-conjugated anti Guinea-pig or anti-Rat, or anti-Mouse (Jackson, USA) (all were used at a dilution of 1:200), biotin anti-Rabbit (1:100) and biotin anti-Guinea pig (1:50) (both from Jackson Labs, USA).
Immunochemical reagents
Embryo staining
Antibody staining was performed essentially as described previously (Nabel-Rosen et al., 1999) . In brief, embryos were collected and incubated as indicated, dechorionated and fixed with a mixture of 3% paraformaldehyde and heptane. Following three washes with PBT (PBS containing 0.1% TritonX-100 or 0.1% Tween for active-Caspase-3 staining), embryos were devitellinized with methanol-heptane mixture. Blocking was performed by incubation in PBT containing 10% BSA for 30 min, followed by incubation with primary antibody for 16 h at R.T. The embryos were then washed, incubated with secondary antibody for 2 h at R.T., washed again and submersed in 80% glycerol. For Diap1 and Hid staining, the ABC peroxidase system (Vector laboratories) was used in order to enhance the sensitivity of the 2nd antibody.
Fluorescent-labeled ventral nerve cord preparations were visualized using BioRad Radiance 2100 confocal microscope coupled to Elipce TE300 Nikon microscope. Bright field and fluorescent digital images were processed using Photoshop version 8.0 (Adobe System Inc. California, USA).
4.4.
In-vitro protein-RNA binding assay
Protein-RNA binding assays were performed essentially as described (Nabel-Rosen et al., 1999) . The cDNAs of diap1-3 0 UTR, stripe-3'UTR, and stripe without the HOW binding sites were used as templates to produce Biotin-labeled RNAs (Biotin labeled mix, Roche, and T7 polymerase, Promega). The Biotin-labeled RNA was purified on G-50 Sephadex Quick Spin Column (Roche), and then mixed with in vitro translated HOW(L) (TNT Ò Coupled Reticulocyte Lysate System, Promega), and precipitated with magnetic Streptavidin beads. Binding was performed by adding 1 lg of biotinlabeled RNA to 5 ll of translated HOW(L). Streptavidinmagnetic beads were first washed with binding buffer, and 300 ll of the beads were added to each binding reaction for 25 min at R.T. The binding reactions containing the magnetic beads were washed, and boiled in Sample Buffer. The magnetic beads where then removed, and the supernatants were analyzed by Western analysis, according to standard procedures as described (Volk, 1992) , using anti HA antibodies (1:2000).
Knockdown of HOW expression in Schneider cells
S2 Schneider cells were resuspended in serum free Schneider medium (Beit Haemek) and plated on a 12 well plates at 1.5 · 10 6 cells per well in the presence of 8.6 lg HOW ds-RNA. After an incubation period of 45 min at 25°C, 1 ml Schneider medium containing 20% serum (FBS Hy Clone) was added and the cells were incubated for 4 days at 25°C. The cells were then collected, and extracted in RIPA (1% DOC, 1% Triton X 100, 0.1% SDS, 0.15 M NaCl, 0.005 M Tris pH 7.0), with protease inhibitor cocktail (Sigma). The sample was then boiled in Sample Buffer, subjected to SDS PAGE-electrophoresis and further processed for Western analysis according to standard procedures described (Volk, 1992) .
Embryos over expressing HOW(L)
A collection of embryos from a cross of homozygous heat shock-gal4 · UAS-how(L), at the age of 10-15 h was heat shocked for 1 h at 37°C, and then further incubated for an additional 2 h at 25°C. The embryos were extracted in RIPA and then boiled in Sample Buffer followed by Western analysis with anti Diap1 antibody. As a control, a collection of heat shock-gal4 flies that underwent a similar heat shock protocol was used.
4.7.
DNA constructs ds-HOW was prepared by PCR using forward and reverse primers containing the T7 promoter sequence followed by a 301 bp sequence complimentary to the HOW gene starting from the ATG (prepared by Ronit Nir, from our laboratory). The PCR product was then isolated and subjected to in vitro transcription using T7 polymerase (T7 Mega Script, Ambion) (prepared by Ronit Nir).
UAS-diap1 3 0 UTR and UAS-diap1 3 0 UTR * were generated by subcloning either diap1containing an intact 3 0 UTR, or a 3 0 UTR in which the HOW binding sites were deleted from its 3'end into the pUASTattB plasmids. The sequences of all DNA constructs described were verified by DNA sequencing.
